Statistics notes. Interaction 1: Heterogeneity of effects.
作者信息
Altman D G, Matthews J N
机构信息
Centre for Statistics in Medicine, Institute of Health Sciences, Oxford.
出版信息
BMJ. 1996 Aug 24;313(7055):486. doi: 10.1136/bmj.313.7055.486.
Abstract
摘要
相似文献
1
Statistics notes. Interaction 1: Heterogeneity of effects.统计学注释。交互作用1：效应的异质性。
BMJ. 1996 Aug 24;313(7055):486. doi: 10.1136/bmj.313.7055.486.
2
Interaction 3: How to examine heterogeneity.互动3：如何检验异质性。
BMJ. 1996 Oct 5;313(7061):862. doi: 10.1136/bmj.313.7061.862.
3
Statistics notes. Interaction 2: Compare effect sizes not P values.统计学笔记。交互作用2：比较效应量而非P值。
BMJ. 1996 Sep 28;313(7060):808. doi: 10.1136/bmj.313.7060.808.
4
Statistics in medicine--reporting of subgroup analyses in clinical trials.医学统计学——临床试验中亚组分析的报告
N Engl J Med. 2007 Nov 22;357(21):2189-94. doi: 10.1056/NEJMsr077003.
5
Statistical standards in journal articles.期刊文章中的统计标准。
Anaesth Intensive Care. 2012 May;40(3):556; author reply 556.
6
[Statistical design in clinical trials].[临床试验中的统计设计]
Med Clin (Barc). 1996 Sep 14;107(8):303-9.
7
Subgroup analyses in clinical trials.临床试验中的亚组分析。
N Engl J Med. 2008 Mar 13;358(11):1199; author reply 1199-200.
8
[Methodologic remarks on the statistical evaluation of a clinical trial].[关于临床试验统计评估的方法学评论]
Methods Inf Med Suppl. 1976;9:17-25.
9
Subgroup analyses in clinical trials.临床试验中的亚组分析。
N Engl J Med. 2008 Mar 13;358(11):1199; author reply 1199-200. doi: 10.1056/NEJMc073436.
10
Statistics notes: variables and parameters.统计学笔记：变量与参数。
BMJ. 1999 Jun 19;318(7199):1667. doi: 10.1136/bmj.318.7199.1667.
引用本文的文献
1
Effectiveness of Self-Training With a Web-Based Digital Health Application Versus Physiotherapy in the Treatment of Disorders of the Patella: Randomized Controlled Trial.基于网络的数字健康应用程序自我训练与物理治疗在治疗髌骨疾病中的有效性：随机对照试验。
J Med Internet Res. 2025 May 5;27:e66463. doi: 10.2196/66463.
2
Global epidemiology of severe fever with thrombocytopenia syndrome virus in human and animals: a systematic review and meta-analysis.全球人类和动物中严重发热伴血小板减少综合征病毒的流行病学：一项系统综述和荟萃分析。
Lancet Reg Health West Pac. 2024 Jul 2;48:101133. doi: 10.1016/j.lanwpc.2024.101133. eCollection 2024 Jul.
3
Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial.在有银屑病关节炎和中轴表现的患者中司库奇尤单抗应答的预测因素：MAXIMISE 试验的事后分析。
RMD Open. 2022 Jul;8(2). doi: 10.1136/rmdopen-2022-002303.
4
Efficacy of early use of remdesivir: a systematic review of subgroup analysis.瑞德西韦早期使用的疗效：亚组分析的系统评价。
Rev Esp Quimioter. 2022 Jun;35(3):249-259. doi: 10.37201/req/154.2021. Epub 2022 Mar 17.
5
Anticoagulants for acute ischaemic stroke.急性缺血性脑卒中的抗凝治疗。
Cochrane Database Syst Rev. 2021 Oct 22;10(10):CD000024. doi: 10.1002/14651858.CD000024.pub5.
6
Prognostic Factors and Treatment-Effect Modifiers in Spinal Muscular Atrophy.脊髓性肌萎缩症的预后因素和治疗效果调节剂。
Clin Pharmacol Ther. 2021 Dec;110(6):1435-1454. doi: 10.1002/cpt.2247. Epub 2021 Jun 5.
7
Disparities in Refusal of Locoregional Treatment for Prostate Adenocarcinoma.前列腺腺癌局部区域治疗拒绝的差异。
JCO Oncol Pract. 2021 Oct;17(10):e1489-e1501. doi: 10.1200/OP.20.00839. Epub 2021 Feb 25.
8
p value variability and subgroup testing.p 值变异性和亚组检验。
Eur J Nutr. 2021 Dec;60(8):4203-4206. doi: 10.1007/s00394-021-02498-z. Epub 2021 Feb 13.
9
Using the Systemic Immune-Inflammation Index (SII) as a Mid-Treatment Marker for Survival among Patients with Stage-III Locally Advanced Non-Small Cell Lung Cancer (NSCLC).利用系统免疫炎症指数（SII）作为 III 期局部晚期非小细胞肺癌（NSCLC）患者治疗中期生存标志物。
Int J Environ Res Public Health. 2020 Oct 30;17(21):7995. doi: 10.3390/ijerph17217995.
10
Feasibility and long-term efficacy of a proactive health program in the treatment of chronic back pain: a randomized controlled trial.主动健康计划治疗慢性腰痛的可行性和长期疗效：一项随机对照试验。
BMC Health Serv Res. 2019 Oct 21;19(1):714. doi: 10.1186/s12913-019-4561-8.
本文引用的文献
1
Back pain and risk of fatal ischaemic heart disease: 13 year follow up of Finnish farmers.背痛与致命性缺血性心脏病风险：对芬兰农民的13年随访
BMJ. 1994 Nov 12;309(6964):1267-8. doi: 10.1136/bmj.309.6964.1267.
2
Multiple significance tests: the Bonferroni method.多重显著性检验：邦费罗尼方法
BMJ. 1995 Jan 21;310(6973):170. doi: 10.1136/bmj.310.6973.170.
3
Evidence for a food additive as a cause of ketosis-prone diabetes.一种食品添加剂作为易发生酮症糖尿病病因的证据。
Lancet. 1981 Oct 3;2(8249):716-20. doi: 10.1016/s0140-6736(81)91048-5.
4
Lead exposure and children's intellectual performance.铅暴露与儿童智力表现。
Int J Epidemiol. 1987 Mar;16(1):57-67. doi: 10.1093/ije/16.1.57.
5
Health effects due to occupational exposure to cobalt blue dye among plate painters in a porcelain factory in Denmark.丹麦一家瓷器厂中制版画家职业接触钴蓝染料对健康的影响。
Scand J Work Environ Health. 1988 Dec;14(6):378-84. doi: 10.5271/sjweh.1903.
6
The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials.早产前使用皮质类固醇的效果：来自对照试验的证据综述
Br J Obstet Gynaecol. 1990 Jan;97(1):11-25. doi: 10.1111/j.1471-0528.1990.tb01711.x.
Zotero 插件